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The ability to model human brain development in vitro represents an important step in our study of
developmental processes and neurological disorders. Protocols that utilize human embryonic and in-
duced pluripotent stem cells can now generate organoids which faithfully recapitulate, on a cell-biolo-
gical and gene expression level, the early period of human embryonic and fetal brain development. In
combination with novel gene editing tools, such as CRISPR, these methods represent an unprecedented
model system in the ﬁeld of mammalian neural development. In this review, we focus on the similarities
of current organoid methods to in vivo brain development, discuss their limitations and potential im-
provements, and explore the future venues of brain organoid research.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The human brain is one of the most complex organs in the
animal kingdom, both structurally and functionally. These char-
acteristics have captured scientists' interest for many years.
However, not only does the brain's complexity present a challenge
for the study of this unique organ, but also its inaccessibility for
experimental manipulation. Therefore, researchers have tradi-
tionally utilized animal models for the study of adult and em-
bryonic brain development. These studies have provided the
foundation for our current understanding of brain development
and function. Nonetheless, understanding of human brain devel-
opment has been limited to those features that are shared among
mammals and other vertebrates. Thus, the study of human or
primate speciﬁc features of the brain have been limited to ob-
servations in post-mortem tissue, and functional studies have,
until very recently, been impossible.
In order to perform functional studies in human brain devel-
opment, researchers were in the need of an in vitro system that
would recapitulate the features of the developing brain in vivo. Just
a decade ago, this was thought to be unattainable. But numerous
studies with tissues and cells cultured ex vivo, and the advent of
pluripotent stem cells, have paved the way for three-dimensional
models of developing neural tissue that model the developingr Inc. This is an open access article
A. Lancaster).brain with remarkable ﬁdelity. The development of such 3D in
vitro cultures, in which cells self organize into complex structures,
has recently brought into usage the term “organoid”, previously an
imprecisely deﬁned term used for many different structures. Cur-
rently, in the context of in vitro cultures, there are ongoing debates
as to at which level of complexity an embryoid body becomes an
organoid. In this review, we will use the term organoid for 3D
cultures which replicate not only the complexity of the cell types
present in the organ, and the processes of self-organization of the
tissue, but also the main organization of the whole organ, in this
context the appearance of different brain regions (Lancaster and
Knoblich, 2014a). By combining the organoid method with re-
cently developed gene editing techniques such as CRISPR, re-
searchers can now study developmental processes and disorders
on an unprecedented level.
In this review, we will discuss the power of three-dimensional
in vitro models with particular emphasis on the comparison to
in vivo development, and how they can be used to model brain
evolution and neurodevelopmental disorders. We will also discuss
the near and far future directions, and how further methodological
improvements could impact the ﬁeld of neurogenesis research and
development of new therapies.2. Establishment of in vitro cultures
The ﬁrst instances of explanting pieces of an organism and
culturing these grafts to monitor the behavior of cells took placeunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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observed neurons growing out from a frog embryo graft cultured
in, what would later become known as, in vitro conditions (Har-
rison, 1906). This is considered the beginning of the tissue culture
era. Numerous researchers since then have contributed to the
elaboration and reﬁnement of in vitro culture, producing methods
to maintain whole tissue grafts for prolonged periods of time, thus
enabling detailed studies of various physiological and cell-biolo-
gical processes taking place. The establishment of the ﬁrst im-
mortal cell lines (Earle et al., 1943; Gey and Coffman, 1952) re-
moved the obstacle of repeated tissue acquisition, and paved the
way for a whole new ﬁeld of cell-biological research.
In the ﬁeld of neuroscience, methods of culturing adult and
embryonic neurons has allowed for careful characterization of
diverse neuronal processes, such as migration from an explant
(Lapham and Markesbery, 1971) and identiﬁcation of axon gui-
dance cues (Kennedy et al., 1994). Although very useful for the
study of neuronal physiology, these cultures can be problematic
because they do not proliferate, and their maintenance is laborious
and very limiting (Hydén, 1959). The establishment of a clonal
neuronal line derived from a mouse neuroblastoma (Augusti-Tocco
and Sato, 1969; Schubert et al., 1969) allowed for a more controlled
production of neurons, thus eliminating the need for repeated
explants. However, these cultures were still hindered by an in-
ability to accurately model developmental events such as timed
neurogenesis.
While two-dimensional cell cultures have provided important
insight into cell biology, these often homogeneous cultures have
unfortunately been lacking when it comes to understanding tissue
development. Animal tissues are composed of a broad repertoire
of cell types organized in complex 3D arrangements, which in-
ﬂuence both cell identity and function. This organization cannot be
recapitulated using traditional in vitro cell culture approaches. For
example, even when cells were taken from the embryonic or adult
forebrain, and were demonstrated to be intrinsically capable of
recapitulating the main events of brain development (differentia-
tion into neurons and glia) (Carpenter et al., 1999; Vescovi et al.,
1999), and even formation of 3D structures called neurospheres
(Reynolds and Weiss, 1992), they were still incapable of modeling
the developing brain accurately. Therefore, in order to more ac-
curately model the development of the tissue, a new approach had
to be adopted, one that would model both the proper 3D organi-
zation and the development of the whole repertoire of tissue cell
types.
A breakthrough in the form of establishment of embryonic
stem (ES) cell lines (Evans and Kaufman, 1981; Martin, 1981;
Thompson et al., 1989), which can be directed into producing cells
of any germ layer, has allowed for the development of in vitro
cultures that more accurately model cell fate conversions during
embryonic development. Then, ten years ago, another leap for-
ward took place, with the introduction of induced pluripotency
(Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007). Induced
pluripotent stem (iPS) cells allow for the formation of a stem cell
line from almost any type of tissue, and consequently present a
highly valuable tool in basic and clinical research as they can be
derived from living human patients.
Since the establishment of these pluripotent stem cell lines,
various approaches have been devised for differentiation of a
range of neural identities. By using a deﬁned set of signaling
molecules, almost any tissue could be produced in vitro, including
neurons from the central and peripheral nervous system. For ex-
ample, spinal motor neurons can be produced by a sequence of
steps which caudalizes and ventralizes the ES cells by using re-
tinoic acid and sonic hedgehog, respectively, thus recapitulating
the in vivo signaling cascade (Wichterle et al., 2002). Using a
controlled protocol of administering supplements, a more faithfuldevelopmental sequence of events could be achieved. However, as
we will see, the human brain possesses an exquisite develop-
mental complexity, and replicating it in vitro has been a huge
challenge. Nonetheless, recent advances using 3D self-organizing
cultures are beginning to provide better models of key neurode-
velopmental events.3. The complexity of the developing human brain
The human brain contains billions of neurons and glial cells,
which form an elaborate and determined pattern of circuitry in the
adult individual. Such complexity is reﬂected in its development,
which takes place throughout most of embryonic and fetal de-
velopment (Malik et al., 2013), and is composed of an intricate
sequence of changes in the progenitor population with different
proliferation potentials. Although a lot of progress has been made
in recent years concerning our knowledge of non-human species,
we will focus here on the development of the human brain. The
human brain, although unremarkable from a gross morphological
point of view, represents one of the most complex, if not the most
complex organ, produced during embryonic development in the
whole of the animal kingdom. The human brain is highly enlarged,
compared to our closest relatives and ancestors, develops slower
and for a longer time, and has a very complex conﬁguration, with
more types of neurons and brain areas, than in other mammalian
lineages (Geschwind and Rakic, 2013).
The human brain starts its development from a closed sheet of
epithelium, the neural tube, populated by precursors of all other
progenitor populations called neuroepithelial (NE) cells (Götz and
Huttner, 2005). The neural tube encloses a ﬂuid-ﬁlled cavity that
later develops into brain ventricles. These elongated cells make up
the whole of the neuroepithelium at early stages of brain devel-
opment (before any neurogenesis commences) and divide by
proliferative divisions in order to increase the number of neural
progenitors, thus expanding the neuroepithelium laterally. As the
layer consisting of NE cells is located right next to the ventricle, it
is termed the ventricular zone (VZ) (Fig. 1A). As in most devel-
oping epithelia, mitoses take place at the apical surface, next to the
ventricle, and in order to reach the right position for cell division,
nuclei of NE cells must undergo a directed movement towards the
apical side of the neuroepithelium, termed interkinetic nuclear
migration (INM), a process which lasts during the whole period of
neurogenesis (Taverna and Huttner, 2010). Just before the onset of
neurogenesis, i.e. before any neurons are born, NE cells change
some of their cell biological features and transform into radial glia
(RG) (Götz and Huttner, 2005). RG switch their division mode from
symmetric, proliferative, to asymmetric, self-renewing division (in
which the progeny consists of one radial glia and one neuron or a
different type of progenitor, see below) (Lancaster and Knoblich,
2012), although they still maintain vertical division planes (Kosodo
et al., 2004).
The moment of ﬁrst birth of neurons marks the onset of neu-
rogenesis, and in human development this happens relatively
early, at 5–6 gestational weeks (GW) (Howard et al., 2008). In
addition to these ﬁrst neurons, RG start producing another type of
progenitor cell, which will lose the epithelial features and dela-
minate from the VZ. As they migrate towards the basal side of the
neuroepithelium, they will establish another progenitor layer
termed the subventricular zone (SVZ) (Fig. 1A), which can be dis-
tinguished from the VZ based on the orientation of the cells, and
on the expression of some molecular markers (Fish et al., 2008;
Smart et al., 2002). These progenitors mostly divide symmetrically
to produce two neurons, and, because they represent an inter-
mediate state between RG and neurons, are termed intermediate
progenitors (IPs) (Haubensak et al., 2004; Miyata et al., 2004;
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Fig. 1. Comparison of in vivo and in vitro brain development. A simpliﬁed representation of the cell biological complexity of the in vivo developing brain and the in vitro brain
organoid. The early stages (left) possess a similar morphological level of complexity. Later stages (right) differ in the size of the cortical wall and diversity and complexity of
neural progenitor populations. Note the absence of vasculature (orange) in the organoid, a reduced SVZ and the rudimentary organization of the neuronal layers. VZ –
ventricular zone, SVZ – subventricular zone, CP – cortical plate.
I. Kelava, M.A. Lancaster / Developmental Biology 420 (2016) 199–209 201Noctor et al., 2004). In addition to IPs, RG produce another type of
progenitor, the basal (bRG) or outer radial glia (oRG) (Fietz et al.,
2010; Hansen et al., 2010; Reillo et al., 2011) (Fig. 1A). bRG also
settle themselves in the SVZ, which in the human is enlarged, as
compared to other species (Smart et al., 2002). These cells then
undergo asymmetric, self-renewing divisions to continue produ-
cing neurons but also replenish themselves. Although previously
thought to be clearly deﬁned and separate subpopulations of
neural progenitors, it appears that IPs and bRGs (now collectively
termed basal progenitors (BPs)) can ﬂuctuate morphologically and
in terms of their proliferative potential (Betizeau et al., 2013). It is
thought that the complexity of the SVZ compartment and the
ability of neural progenitors to remain or switch to a “more pro-
liferative” state, coupled with the length of neurogenesis, may
have contributed to evolutionary expansion of the neocortex. This
expansion is noticeable in several mammalian lineages, but the
human lineage especially stands out in this regard (Lewitus et al.,
2014). In the end, all types of neural progenitors give rise to
neurons, which migrate basally, using the RG processes. They
settle themselves in well-organized layers, which have an inside-out pattern (the oldest-born neurons make up the deepest layers),
ﬁnally making up the mature, six-layered cortical plate of an adult
neocortex.4. Modeling human brain developmental complexity in vitro
Even this very simpliﬁed description of human neocortical
neurogenesis (for details of cell-biological features of neural pro-
genitors, please see recent reviews (de Juan Romero and Borrell,
2015; Fernández et al., 2016; Florio and Huttner, 2014; Lui et al.,
2011; Paridaen and Huttner, 2014; Taverna et al., 2014)) hopefully
gives some indication of the complexity of cell biological and
morphological changes that need to take place in order for a
mature and functional adult brain to develop. Therefore it is re-
markable that some in vitro protocols have managed to faithfully
recapitulate a signiﬁcant portion of the neurogenic period. The
ﬁrst protocols that mimicked some of the morphological aspect of
the developing neocortex were 2D cultures, in which human ES or
iPS cells were directed into cortical precursors by using different
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of these systems was the organization of cells into neural rosettes,
i.e. cells surrounding a central lumen and undergoing mitoses at
the luminal side (Chambers et al., 2009; Elkabetz et al., 2008;
Zhang et al., 2001). This organization is highly reminiscent of the
organization in vivo in which NE cells and RG are organized ra-
dially around a ﬂuid-ﬁlled ventricle. Furthermore, neural pro-
genitors exhibited temporally controlled neuronal production, as
evidenced by the successive emergence of molecular markers
characteristic of different neuronal layers (Chambers et al., 2009;
Elkabetz et al., 2008; Gaspard et al., 2008). This speaks to an in-
trinsic mechanism of in vitro derived neural progenitor cells,
which are able to recapitulate the major milestones in the pro-
duction of neocortical neurons. Subsequent improvement of this
2D method saw an increase in the complexity of the composition
of neural rosettes, together with improved morphological simila-
rities, like well-established INM (Shi et al., 2012). This method also
produced a more complex conﬁguration of neural progenitors,
including bRG-like cells, with the typical morphology and mole-
cular signature (PAX6 expression). An important quality of these
methods is that they give rise to layer-speciﬁc neurons, which are
capable of producing action potentials (Espuny-Camacho et al.,
2013; Kirwan et al., 2015; Shi et al., 2012), develop synapses (Shi
et al., 2012) and, when grafted into a cortex of mice, can integrate
successfully among cortical neurons in a layer-speciﬁc manner
(Espuny-Camacho et al., 2013; Gaspard et al., 2008).
A crucial advance in approaching an in vitromodel more similar
to the in vivo developing brain was made with the introduction of
3D culture methods (Eiraku et al., 2008; Watanabe et al., 2005),
and further improvements of this serum-free culture of embryoid
body-like aggregates (SFEB) (Mariani et al., 2012; Paşca et al.,
2015). Here, in addition to characteristics already achieved by 2D
cultures (INM, different progenitor populations, sequential birth of
neurons characteristic of different layers), the cultures showed a
well-deﬁned ventricle, with a clearly distinguishable VZ and SVZ
(Fig. 1B). Further studies combined the ﬂoating 3D aggregate ap-
proach with components of extracellular matrix (ECM), either by
dissolving it in the medium (Kadoshima et al., 2013; Nasu et al.,
2012), replating the free-ﬂoating cultures onto ECM-coated dishes
(Mariani et al., 2012), or by embedding the growing embryoid
bodies into pure Matrigel (Lancaster et al., 2013). These studies
demonstrated the importance of the ECM as a crucial cue for
proper organization of the neuroepithelium in vitro (Nasu et al.,
2012). ECM components improved the polarization of the neural
progenitor sheets and supported the development of elongated
neuroepithelia, which surrounded lumina resembling the in vivo
ventricles, and not just rosette formations. A signiﬁcant improve-
ment was also the appearance of neuronal “layers”, in which earlier
born neurons, as labeled by deep-layer markers, were situated
below later born neurons, as in the developing human brain (Ka-
doshima et al., 2013; Lancaster et al., 2013; Nasu et al., 2012). This
layering is rudimentary (Fig. 1B, right – note the irregular ar-
rangement of neurons, as compared to the in vivo brain), and does
not persist throughout the late stages of the culture, after all of the
neuronal layers have been born. A signiﬁcant improvement was
presented in a recent study (Qian et al., 2016), which showed the
generation of neurons corresponding to all six layers. We are
conﬁdent that further developments will build on these protocols
and phenocopy other human developing brain characteristics (e.g.
preplate splitting).
We have so far neglected culture methods that support the
development of parts of the brain other than the neocortex. The
majority of methods described to date have established ap-
proaches for the selective generation of particular brain regions
(pituitary (Suga et al., 2011), hypothalamus (Wataya et al., 2008),
cerebellum (Muguruma et al., 2015; 2010), retina (Eiraku et al.,2011)) and/or for the speciﬁc promotion of the telencephalic
(forebrain) fate, by the addition of patterning factors. An alter-
native approach using combined Matrigel embedding and free
ﬂoating conditions that bypasses the need for using signaling
molecules instead leads to the generation of a variety of brain
regional identities (Lancaster et al., 2013). Because of the presence
of broad regional identities, this method was termed cerebral or-
ganoids, or brain organoids. In turn, it allows for self-patterning
and self-organization processes to take place, resulting in distinct
and interdependent brain regions appearing in the same organoid.
These discrete brain regions are not randomly dispersed around
the organoid, but show some patterns of regionalization as in the
early developing brain, e.g. establishment of midbrain/hindbrain
boundary with appropriate regions located adjacent to each other.
Additionally, organoids exhibit some of the features of regional
connections, with interneurons, which in vivo are partly produced
in the ventral forebrain and migrate to the dorsal cortex (Nakaji-
ma, 2012; Wonders and Anderson, 2006), showing a similar pat-
tern of migration in the organoids. It will be interesting to further
study these potential communication pathways in the whole brain
cultures, and whether the cues driving these migration trails
correspond to the ones observed in vivo.
On a cellular level, organoids show a high level of similarity to
the in vivo developing human brain in the early stages of devel-
opment. The progenitor zones (VZ and SVZ) are easily recogniz-
able, as in previously described methods, but the zones show a
higher degree of complexity and sub-compartmentalization into
an inner- and outer SVZ, which are separated by a neuronal ﬁber
layer (Lancaster et al., 2013; Smart et al., 2002). The bRG also ap-
pear relatively frequently, although not as often as in the devel-
oping human brain (Fig. 1B). Due to the method limitations (lack of
vascularization), the organoids are not able to mimic later stages of
neurogenesis (see below).
The previously mentioned methods of neocortical cultures
show varying degrees of similarity to the developing human brain
in vivo. However, human neocortical development is, as any other
developmental process, comprised not only of obvious cellular
differences in morphology and the small palette of markers that
we have access to, but has to employ coordinated waves of gene
expression in order to induce all of the morphological changes and
patterning cues needed to develop a functioning brain. In order to
determine the similarities of the in vitro methods to in vivo brain
development, several studies have recently employed gene ex-
pression analyses on neocortical cultures by microarrays (Mariani
et al., 2012; Paşca et al., 2015), RNA-seq (Mariani et al., 2015; Qian
et al., 2016; van de Leemput et al., 2014) or single-cell RNA-seq
(Camp et al., 2015), and compared it to gene expression of the
developing brain (Camp et al., 2015; Kang et al., 2011; Miller et al.,
2014). These studies all reported that in vitro methods replicate
remarkably well early in vivo brain development (middle and end
of the 8–10 gestation weeks (GW)), with some reports that the in
vitro development parallels the in vivo up to late mid-fetal period
(19–24 GW) (Paşca et al., 2015; Qian et al., 2016) (Fig. 2). All of the
methods showed the correct employment of the frontal brain
neurogenic program, conﬁrming cell-biological analyses. A de-
tailed, single-cell transcriptome analysis corroborated the cell-
biological analyses and found that the in vitro methods produce
relatively less BPs, as compared to the in vivo neocortical devel-
opment (Camp et al., 2015). These differences are an obvious
consequence of the methods’ limitations – the inability to vascu-
larize the cultures and the possible lack of some intrinsic and
extrinsic cues, which are not replicated with the current protocols.
However, when transcriptomes of individual organoid cells were
compared to the transcriptomes of the cells of the same lineage
from an in vivo brain, the main differences did not come from the
method of origin (in vitro versus in vivo), but from the state of cells
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between the organoid and the in vivo cells that this study picked
up, are mostly in the genes which have a low expression in the
fetal brain, or in the genes that reﬂect the composition of the in
vitro media culture and the responses to the factors present
therein (Camp et al., 2015).
Taken together, the cell-biological, temporal and gene expres-
sion similarities between in vitro neocortical cultures and in vivo
developing brain show that we are currently able to model early
human neocortical development accurately. This opens the door to
studies of human-speciﬁc brain disorders and basic biological
mechanisms of development. The possible uses of these systems
are boundless and have the potential to overcome the frequently
observed lack of translation from animal studies. In addition, there
is a further beneﬁt with regard to ethical considerations of using
animals where there is the potential to limit the numbers of ani-
mals needed for neurodevelopmental studies.5. Modeling neurodevelopmental disorders in vitro
The faithful recapitulation of brain developmental processes is
a relatively new event, so it does not surprise that studies usingC
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organoids to study idiopathic autism. Organoids generated from patients showed an i
healthy relatives.these 3D methods are still few. However, the ﬁeld of develop-
mental organoid research is currently booming (Fatehullah et al.,
2016; Huch and Koo, 2015; Passier et al., 2016; Suzuki and Van-
derhaeghen, 2015; Yin et al., 2016) and we can expect a surge of
studies in the near future.
The study that ﬁrst described the protocol for growing growth
factor-free organoids also used them to study a human neurode-
velopmental disorder, primary microcephaly (Lancaster et al.,
2013; Woods et al., 2005) (Fig. 3A). Truncating mutations in the
CDK5RAP2 gene inﬂuence the neocortical progenitor pool and
result in an overall smaller brain (Bond et al., 2005; Buchman
et al., 2010). However, previous studies were conducted with
mouse models, which did not recapitulate the symptoms of mi-
crocephaly at the same level as in humans. Fibroblasts from a se-
vere microcephaly patient with CDK5RAP2 truncating mutations
were used to produce iPS cells and grow organoids. These orga-
noids already showed a crude phenotype, by being smaller than
wild-type brain organoids. Analysis of neural progenitors in pa-
tient-derived organoids showed that they had an increased pro-
portion of mitotic divisional planes that were not perpendicular to
the ventricular surface. This is in contrast to the wild-type situa-
tion, in which the maintenance of the division plane perpendicular
to the ventricular surface is crucial for the upkeep of theIdiopathic ASD
with macrocephaly
Unaffected relative
GABAergic inhibitory
neuron
et al., 2013. used brain organoids to study brain development in a microcephalic
oduced from the patient were smaller than the control, and had a change in the
nitor pool, and thus to the smaller brain size. (B) Mariani et al., 2015. used brain
ncrease in GABAergic inhibitory neurons (depicted in green), as compared to the
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and neurogenesis (Lancaster and Knoblich, 2012) (Fig. 3A, right).
The change in mitotic plane orientation might inﬂuence this
sensitive balance and cause premature neuronal differentiation, by
a mechanism similar to the one observed in the mouse model
(Buchman et al., 2010). Microcephaly is coming into focus again,
this time not only in the scientiﬁc community, but also in the
general public, due to the current epidemic of the Zika virus, and
its potential link to an increased number of infants born with
severe microcephaly (Heymann et al., 2016). In this context, brain
organoids have been a powerful tool for the rapid analysis of the
effects of Zika on human brain development, providing insight in
an extremely short time period. Several very recent studies re-
ported an effect of Zika on neural stem cells (Tang et al., 2016)
and on brain organoids (Cugola et al., 2016; Dang et al., 2016;
Garcez et al., 2016; Qian et al., 2016). For example, the report by
Qian et al. (2016) which used pure forebrain organoids, showed
that the early exposure to two different strains of Zika virus in-
ﬂuenced the proliferation of cells in the VZ and caused a phe-
notype resembling microcephaly observed in children prenatally
exposed to the virus. Furthermore, although not directly ana-
lyzing the mechanism of Zika virus infection, Nowakowski et al.
(2016) used brain organoids to identify a possible point of entry
of the virus into neural progenitors. Finally, Dang et al. (2016)
reported activation of innate immune signaling in cerebral or-
ganoids infected with Zika, suggesting a potential mechanism for
apoptosis in neural progenitors.
Another neurodevelopmental disorder recently studied in or-
ganoids is autism spectrum disorder (ASD) (Geschwind, 2009)
(Fig. 3B). Mariani et al. (2015) used iPS cell-derived organoids from
patients with idiopathic ASD to study the processes taking place
during neocortical neurogenesis that may contribute to the de-
scribed complex pathologies. ASD-derived organoids, and their
comparison to wild type organoids, showed that in the patients
the early neural progenitors had a decreased cell cycle length,
resulting in their over-proliferation. An additional feature of ASD
organoids was that the production of GABAergic neurons was in-
creased, due to the increase in expression of FOXG1, a gene in-
volved in the production of early cortical neurons and in some
ASDs with prenatal microcephaly (Hanashima et al., 2004; Jacob
et al., 2009) (Fig. 3B, right). The ASD organoids also exhibited
overgrowth of neurites and an increase in the number of synapses,
which is one of the characteristics found in some post-mortem
studies of ASD patients (Hutsler and Zhang, 2010). This study
showed that the prenatal alterations in the proliferation/neuro-
genesis equilibrium could be one of the main features of at least a
subset of ASDs, and it creates opportunities for focused prenatal
diagnostics and drugs that might suppress the abnormal pheno-
type and/or alleviate the symptoms.
Schizophrenia represents another debilitating disorder, origins
of which are thought to come partly from a disruption of neuro-
development (Rapoport et al., 2012). Some regions of the genome
show particular association with an increased risk of schizo-
phrenia (Malhotra and Sebat, 2012), but the underlying mechan-
isms remain elusive. Yoon et al. (2014) used iPS cells-derived from
patients with a deletion in one of the regions implicated in in-
creased schizophrenia risk (15q11.2) to derive neural rosettes
which model the behavior of early cortical neural progenitors. The
authors noticed that, in the patient derived rosettes, the APs had a
disrupted apical region, as labeled by the apical polarity markers.
Although preliminary, the study captures the cellular phenotype,
which follows from a particular aberrant genomic rearrangement,
implicated in several neurological disorders. Further studies will
hopefully delve deeper into the etiology of these complex dis-
orders, and brain organoids will likely provide an important tool in
these studies.From a handful of studies that used brain organoids to study
neurodevelopmental disorders, it is already apparent that these
methods hold immense opportunities for studying human-speciﬁc
disorders, which cannot be adequately modeled in the mouse (e.g.
microcephaly, schizophrenia, autism). It is important to stress that,
although the organoid method mimics human brain development
remarkably well, there are many limitations, which hamper their
use for the study of certain neuropathologies.6. Limitations of the current methods
Understandably, in vitro organoid culture takes place without
the normally present embryonic surrounding. This allows for the
visualization of processes taking place in the tissue and manip-
ulation of organogenesis, but it also means that the organoid tis-
sue lacks essential developmental and patterning cues, which are
necessary for development into a fully formed, mature organ. For
brain organoids speciﬁcally, the lack of body axes mean that, al-
though the organoids develop discrete brain regions, they do not
organize themselves in the same pattern as present in vivo (Lan-
caster et al., 2013). Furthermore, the organoid method still suffers
from the “batch syndrome”, in which different batches of orga-
noids show signiﬁcant variability in quality and brain regions they
produce (Lancaster and Knoblich, 2014b). A recent development in
this direction is the establishment of pure forebrain organoids,
which, by changing the protocol conditions, can be directed into
producing other region-speciﬁc organoids (Qian et al., 2016). Fur-
ther improvements of the method, together with technical de-
velopments should be aimed at producing homogeneous, correctly
patterned organoids.
A further limiting factor in the in vitro culture is the lack of
vascularization. Early development of the neocortex progresses
without vasculature, before blood vessels invade the cortical wall
(Vasudevan et al., 2008). Late development, however, is highly
dependent on the vascularization of the SVZ (Fig. 1B, right), as the
proximity of the blood vessels represents a niche for neural pro-
genitors (Javaherian and Kriegstein, 2009) and is necessary for
efﬁcient neural progenitor differentiation (Lange et al., 2016). This
lack of vascularization is probably one of the factors inﬂuencing
the scarcity of the SVZ progenitors and might also be partly re-
sponsible for the difﬁculties researchers have encountered in try-
ing to replicate correct cortical plate formation. In order to faith-
fully model in vivo development, with all of its progenitor com-
plexity, it is necessary to focus the efforts on delivering signaling
molecules deep inside the tissue, either by means of cell culture
modiﬁcations, or by engineering innovations. In addition, the
problem of oxygen penetration renders the center of the organoid
necrotic, which could interfere with its normal development,
physiology and potential neuronal migration routes.
Improvements in the organoid method will allow for a
widening of the range of topics and problems that can be studied
(Fig. 4). The ability of organoids to model later embryonic and fetal
development will allow us to study the establishment of circuits
and connectivity. Although cultures of neurons and organoids
make functional synapses, we are still unable to maintain the
cultures in conditions ideal for the establishment of proper cir-
cuitry. It appears that the current 3D organoid protocols favor
progenitor cells, and the current media formulations do not sup-
port the establishment of mature synapses. Therefore it is neces-
sary to adjust the conditions which, later in the organoid gen-
eration protocol, support neurophysiological activity (Bardy et al.,
2015). This will be especially useful for further studies of schizo-
phrenia and similar disorders, which are considered disorders of
cortical connectivity, and a subset of them have a neurodevelop-
mental origin (Brennand et al., 2011; Rapoport et al., 2012).
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Fig. 4. Potential future brain modeling capabilities. A simpliﬁed schematic representing human brain development timescale, indicating several milestones during em-
bryonic development (green), which could be modeling in brain ogranoids in future, following certain technical improvements (dark purple, for details, please see main text)
(for a more detailed timescale of milestones, please see (Silbereis et al., 2016)). The timescale also indicates the onset of a subset of neurodevelopmental and neurological
diseases, which could be modeled (or partly already are) by using the brain organoid technique (petrol color).
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organoids present an excellent model for studying early human
brain development, tissue morphogenesis, proliferation of neural
progenitors, and their transformations from one cell state to an-
other. Further reﬁnements of the protocols will allow for the study
of more complex interactions in the developing brain, like cell–cell
(inﬂuences of progenitors and neurons on each other, synapses
and connectivity) and cell-environment interactions (hypoxia,
exposure to chemicals).7. Brain organoids of the future
Brain organoids (and organoid systems in general), which
adequately model tissue development and physiology, are a rela-
tively new development, and the ﬁeld has exploded in the last
several years. Thus, it is easy to envisage that in 10–20 years from
now (or even less) we will be able to almost fully mimic devel-
opment of certain tissues in vitro. In addition, further improve-
ments in the technique might allow us to model adult brain
physiology and disorders of the adult and ageing brain.
The problem of heterogeneity of whole-brain organoids (see
Chapter 5) might be solved by a combination of the accumulation
of knowledge about stem cells and further technological im-
provements. New research about stem cells will bring about a
deeper understanding of the starting material and the organoids
produced thereof. As accumulating evidence shows that hES cells
show signiﬁcant variability which depends on the cell line (Rugg-
Gunn et al., 2007), passage (Li et al., 2007), and even size of the
colonies and the position of cells within the colony (Bauwens
et al., 2008; Rosowski et al., 2015), careful choice of the cell line,
method of reprogramming into iPS cells and handling of the cells
have to be taken into account when developing new protocols.
Correct axial patterning signals, which would in turn inﬂuence the
predictable appearance of different brain regions could be deliv-
ered to the organoids by using signal-releasing beads, or by
growing organoids on carriers coated with signaling molecules.
Some general protocols, which include combining tissue-spe-
ciﬁc cells with mesenchymal cells, to facilitate tissue vasculariza-
tion upon transplantation of an organ bud (Takebe et al., 2015),
could represent the foundations upon which novel organoidprotocols with incorporated vascularization could be built. An-
other way to overcome the lack of vascularization could be a
bioengeineering approach using microﬂuidic chambers (Bhatia
and Ingber, 2014; van Duinen et al., 2015), which could drive the
ﬂow of ﬂuid through the organoid and thus serve as vasculature.
Growing organoids directly on a microﬂuidic chip (Giobbe et al.,
2015), with the combination of signaling molecule carriers, to
enable proper patterning, might be the way to go. In our efforts to
develop vascularized organoids, we should also incorporate les-
sons from cancer research, as it is well established that tumors
actively promote angiogenesis (Hanahan and Weinberg, 2011).
Improving the conditions for late stages of neurogenesis in the
organoid culture might bring about the induction of myelination,
which in humans is mostly a postnatal process, but it starts pre-
natally. Trisomy 21, or Down syndrome (DS) is one of the most
common causes of intellectual disability (Hartley et al., 2015). It
appears that the gene expression disequilibrium, caused by an
additional copy of chromosome 21, has a profound effect on cor-
tical neurogenesis, and especially on oligodendrocytes and the
myelination process (Chakrabarti et al., 2010; Olmos-Serrano et al.,
2016). Patient-derived brain organoids would allow for a detailed
study of aberrant cortical development and the development of
potential therapeutic strategies that would improve the myelina-
tion process in DS-sufferers. As the gene for amyloid precursor
protein (APP), which is one of the main players in the develop-
ment of Alzheimer's disease (AD), is on chromosome 21, people
with DS have a markedly increased risk of developing this dis-
order, making DS organoids valuable also for modeling AD.
In the case of AD, most cases of the disease are late-onset, i.e.
appear in individuals of 65 years of age and older. Currently we are
using mouse models for both DS and AD, but, although very useful,
they are inadequate to correctly model the etiology and progres-
sion of these complex human disorders (Hartley et al., 2015). Or-
ganoids of the future, which model the physiology of ageing
neurons, might be able to provide further insight into cellular and
molecular mechanisms of pathology and aid in developing drugs
and treatments for the prevention and alleviation of disease
symptoms. Interestingly, some DS sufferers do not develop AD
(Wiseman et al., 2015), and these individuals and their derived
organoids could prove instrumental in deciphering the genetic
backgrounds than confer resistance to early-onset AD.
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most challenging, but also the most rewarding aim of future im-
provements. The interaction of blood vessels and the brain tissue
itself is a ﬁeld with high potential for direct clinical applications.
The delivery of drugs to brain tissue is limited by the blood-brain
barrier, which restricts the admission of chemicals to neurons, so
modeling it faithfully will allow us to improve the efﬁciency of
drug application, and the physiology of drug transport through the
blood-brain barrier. In addition, the blood-brain barrier is dys-
functional or compromised in many brain disorders (Abbott, 2013;
Zhao et al., 2015; Zlokovic, 2011), and a vascularized brain orga-
noid would be a powerful asset in fully comprehending the
etiology of these neurological diseases. Furthermore, it appears
that the disruption of the blood-brain barrier is a common feature
of the aging process (Montagne et al., 2015), and this would re-
present an interesting avenue of discovery. Finally, vascularized
organoids, which mimic adult brain physiology, could also be used
as models for stroke and post-stroke recovery and present an ideal
platform for drug testing.
There are many other diseases of the adult central nervous
system that are excellent candidates to be studied in brain orga-
noids. Just to name a few, Parkinson's disease, Huntington's dis-
ease, and various motor neuron diseases are debilitating disorders
which affect an increasing number of individuals, as the average
human life span rises. Of particular interest is Huntington's dis-
ease, a debilitating heritable condition, brought about by an in-
crease in the number of glutamine repeats (polyQ) in the gene
huntingtin (Brouwer et al., 2009; Li and Bonini, 2010). As the se-
verity and the age of onset of the phenotype depends on the
number of polyQ repeats, a combination of the organoid method
and CRISPR gene editing technique might give us insight into the
mechanisms by which these repeats cause the disease. The same
approach could be applied to other polyQ neurological diseases.
“Personalized organoids” – organoids directly derived from the
affected person, together with drug testing, would represent an
effective clinical usage of the organoid method (Brennand et al.,
2015; Fatehullah et al., 2016; Wen et al., 2016) (Fig. 5). Persona-
lized medicine would mean that clinicians and researchers would
need to obtain cells from a patient, grow brain organoids on a high
throughput scale and test the effectiveness of a large set of drugs,
ﬁnding the ones most appropriate for the patient. A similar pi-
peline might be envisaged as a part of preventive medicine, or
even prenatal diagnostics, as non-invasive methods of embryo
genome analysis and cell acquisition are developed (Gregg et al.,
2013). Both of these strategies call for the establishment of orga-
noid production on a higher scale. With current methods, orga-
noids can be produced in the hundreds, but in order to test a
palette of drugs, one would need to produce thousands ofP
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Fig. 5. Personalized medicine using brain organoids. Brain organoids in the future might
part of a preventive monitoring or disease diagnostics) or cells derived from the embr
organoids on a large scale could be generated. This large number of organoids could be us
to test the outcome on the brain phenotype. With this in mind, personalized therapeutorganoids from a single individual. Automation of the process will
be of crucial importance in this. An exciting new step forward has
been made recently, with the development of a 3D-printed, scal-
able set of mini bioreactors named SpinΩ, which allows for par-
alleled production of a large number of organoids and under
various conditions (Qian et al., 2016).
Although mostly discussed in the context of human brain de-
velopment and human pathologies, brain organoids also provide a
platform for evolutionary studies, enabling direct comparison be-
tween development of species, brains of which are not readily
available (e.g. apes and primates) (Otani et al., 2016). As the ﬁeld of
comparative cell biology of neocortical neurogenesis recently ex-
perienced a renaissance (Fietz et al., 2010; García-Moreno and
Molnár, 2015; García-Moreno et al., 2012; Kelava et al., 2012; Le-
witus et al., 2014; Reillo et al., 2011), we are sure that the devel-
opment of protocols for different mammalian species will deepen
our insight into evolutionary aspects of neurogenesis.
Although some of the future ideas presented in this chapter are
still science ﬁction, we believe that it is necessary to discuss po-
tential long-term or even far-fetched goals, in order to inspire
different ways of thinking and encourage tighter collaborations
among basic researchers, clinicians and bioengineers. We are
convinced that a multidisciplinary approach such as this will yield
new insights and has the most potential to drive the ﬁeld forward.8. Conclusion
In this review we presented the current state of the ﬁeld of
brain organoid research, with special attention to how well the
current protocols recapitulate human brain development. We have
also introduced the current limitations of the technique, and what
the logical next steps may be in the development of these meth-
ods. What is clear is that, although tremendous advances have
been made in improving the in vitro culture of developing neural
tissues, these methods are not without their faults and limitations.
Improvements in the techniques will allow for more complex
processes to be studied, including intricate cell-cell interactions
and migration in the developing brain. Furthermore, diseases
other than severe, early neurodevelopmental disorders could be
modeled, with the potential to model more common, but also
more subtle, disorders. With our outlook into the future, we would
like to emphasize the vast potential of brain organoid research and
inspire future methodological improvements.Genetic screens
Genome editing
Drug screens
Individual therapy
be used in a personalized medicine approach. Individual-derived cells (obtained as a
yo as a part of prenatal diagnostics can be reprogrammed into iPS cells, and brain
ed for genetic screens and drug screening. Genome editing could also be performed
ic strategies may be designed.
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